Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

TAK holding history

Takeda Pharmaceutical Co Ltd in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TAK overviewAll 13F holders of TAKFull Q2 2026 holdings

Shares (Q2 2026)
28,293
Value
$453.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TAK by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202628,293$453.6K<0.1%+3,642+14.8%AddedHolders
Q1 202624,651$456.6K<0.1%+2,343+10.5%AddedHolders
Q4 202522,308$347.8K<0.1%−1,529−6.4%ReducedHolders
Q3 202523,837$349.0K<0.1%−501−2.1%ReducedHolders
Q2 202524,338$376.3K<0.1%+4,485+22.6%AddedHolders
Q1 202519,853$295.2K<0.1%+3,479+21.2%AddedHolders
Q4 202416,374$216.8K<0.1%+6,977+74.2%AddedHolders
Q3 20249,397$133.6K<0.1%+3,822+68.6%AddedHolders
Q2 20245,575$72.1K<0.1%−894−13.8%ReducedHolders
Q1 20246,469$89.9K<0.1%+1,089+20.2%AddedHolders
Q4 20235,380$76.8K<0.1%−1,780−24.9%ReducedHolders
Q3 20237,160$110.8K<0.1%+552+8.4%AddedHolders
Q2 20236,608$103.8K<0.1%+1,533+30.2%AddedHolders
Q1 20235,075$83.6K<0.1%+1,623+47.0%AddedHolders
Q4 20223,452$53.9K<0.1%−7,904−69.6%ReducedHolders
Q3 202211,356$147.0K<0.1%+640+6.0%AddedHolders
Q2 202210,716$150.0K<0.1%+644+6.4%AddedHolders
Q1 202210,072$145.0K<0.1%+2,817+38.8%AddedHolders
Q4 20217,255$99.0K<0.1%+1,342+22.7%AddedHolders
Q3 20215,913$97.0K<0.1%+1,377+30.4%AddedHolders
Q2 20214,536$76.0K<0.1%−222−4.7%ReducedHolders
Q1 20214,758$87.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.